Cited by 492Chemical Synthesis and AnalysisMonoclonal and Polyclonal Antibodies ResearchBacteriophages and microbial interactions

Phage display: Concept, innovations, applications and future

Pande, Jyoti, Szewczyk, Magdalena M., Grover, Ashok K.·2010·Biotechnology Advances

Abstract

Phage display is the technology that allows expression of exogenous (poly)peptides on the surface of phage particles. The concept is simple in principle: a library of phage particles expressing a wide diversity of peptides is used to select those that bind the desired target. The filamentous phage M13 is the most commonly used vector to create random peptide display libraries. Several methods including recombinant techniques have been developed to increase the diversity of the library. On the other extreme, libraries with various biases can be created for specific purposes. For instance, when the sequence of the peptide that binds the target is known, its affinity and selectivity can be increased by screening libraries created with limited mutagenesis of the peptide. Phage libraries are screened for binding to synthetic or native targets. The initial screening of library by basic biopanning has been extended to column chromatography including negative screening and competition between selected phage clones to identify high affinity ligands with greater target specificity. The rapid isolation of specific ligands by phage display is advantageous in many applications including selection of inhibitors for the active and allosteric sites of the enzymes, receptor agonists and antagonists, and G-protein binding modulatory peptides. Phage display has been used in epitope mapping and analysis of protein-protein interactions. The specific ligands isolated from phage libraries can be us…

Integrity signals

Registry

Crossref · 10.1016/j.biotechadv.2010.07.004

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 118 · Cited by 492

Authors
Pande, J., Szewczyk, M. M., & Grover, A. K.
Affiliations
McMaster University (CA)
Corresponding author
Grover, Ashok K.
Venue
Biotechnology Advances
Publisher
Elsevier BV
Published
2010-11
Volume
28
Issue
6
Pages
849-858
ISSN
0734-9750 (ISSN-L)
OpenAlex
W2046319392
Cited by
492
References
118
Citations by year
2026: 18 · 2025: 20 · 2024: 30 · 2023: 32 · 2022: 33 · 2021: 35 · 2020: 26 · 2019: 37 · 2018: 32 · 2017: 30 · 2016: 35 · 2015: 33 · 2014: 43 · 2013: 31 · 2012: 26
FWCI
2.46
Type
journal article
Language
en
Open access
closed
Locations
  • Biotechnology Advances (publishedVersion)
  • PubMed (publishedVersion)
Funders
Heart and Stroke Foundation of Canada
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chemical Synthesis and Analysis
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
  • Physical Sciences › Environmental Science › Ecology › Bacteriophages and microbial interactions
Keywords
phage display, random peptide library, biopanning, ligand discovery, enzyme inhibitors, receptor agonists and antagonists, epitope mapping, protein-protein interaction, drug target validation, drug design, vaccine development, library diversity
MeSH terms
Bacteriophages, Peptides, Protein Binding, Mutagenesis, Peptide Library

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review